7 Jan 2020 The developer, Brighter AB (publ), has not provided details about its privacy practices and handling of data to Apple. For more information, see

Brighter AB (publ) | 1887 followers on LinkedIn. Brighter is a Swedish health-tech company simplifying and improving life through human innovation. | Brighter

Publicerad: 2020-12-30 (Cision) Brighter AB (publ): Brighter signs 5-year agreement and receives initial order for Actiste® worth EUR 1.2 Million in Ghana Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We are currently focused on treating diabetes through our solution Actiste, the world’s first unified diabetes care device with a mobile connection. Brighter AB (publ) ("Bolaget" eller "Brighter") har tecknat ett femårigt distributionsavtal med Wssonlines Nigeria Ltd i Nigeria ("Distributören") avseende Brighters banbrytande produktportfölj för diabetes, Actiste® ("Actiste-tjänsten”). Både Actiste® och den nyutvecklade Actiste® Mini inkluderas i avtalet.

Actiste brighter

The device makes life easier for people with diabetes, lets caregivers provide better patient support, provides medical data for research and reduces overall lifecycle costs. Brighter AB (publ) is proud to announce that its pioneering solution for improved diabetes management – the Actiste® device and its associated digital platform – has received market approval from the Saudi Food and Drug Authority (SFDA). Learn more about Actiste: https://actiste.com/Learn more about Brighter: https://www.brighter.se/ SWEDEN – July 7, 2016 – Brighter AB today announced a partnership with Sanmina to produce the first generation of Actiste®, a connected diabetes device that allows users to monitor blood sugar, inject insulin and log blood sugar levels and insulin doses in a single device. 11 Oct, 2016 Brighter genomför riktad nyemission om 11,2 MSEK.

Brighter AB (publ) är stolt att tillkännage att Actiste®-enheten och den nyutvecklade Actiste® Mini-enheten har erhållit marknadsgodkännande Brighter tecknar 5-årigt avtal och erhåller initial order av Actiste® värd EUR 1,2 miljoner i Ghana (Cision). 2020-12-30 15:10.

Brighter AB (publ) ("Bolaget" eller "Brighter") har tecknat ett femårigt distributionsavtal med Wssonlines Nigeria Ltd i Nigeria ("Distributören") avseende Brighters banbrytande produktportfölj för diabetes, Actiste® ("Actiste-tjänsten”). Både Actiste® och den nyutvecklade Actiste® Mini inkluderas i avtalet.

Brighter AB (publ)s vinstmarginal låg vid senaste årsbokslutet på -22 675,5 % vilket ger Brighter AB (publ) placeringen 405 028 i Sverige av totalt 652 334 aktiebolag. Learn more about Actiste: https://actiste.com/ Learn more about Brighter: https://www.brighter.se/ About Brighter AB. Brighter develops solutions for data-driven and mobile health services. Through its intellectual property and our first innovative solution Actiste®, the company creates a more efficient care chain with focus on the individual. Brighter is a Swedish healthtech company addressing common welfare challenges of modern society through a group of innovation companies.

Brighter initiated activity on multiple fronts following the issue of CE marks for its lead product, Actiste. It acquired Nectarine Health, a Swedish healthtech start-up, to complement its other assisted care solutions acquisition, Camanio. Brighter also entered into a strategic partnership with Accumbo, a digital healthcare provider, to support the visibility of Actiste in the Swedish market

BrightAnalytics bloeit en groeit volop. Wij zoeken enthousiaste en ambitieuze mensen, die mee willen bouwen aan ons verhaal. Actiste familjens produkter och tjänster erbjuds via abonnemang. Actiste® och The Benefit Loop® är varumärken som tillhör Brighter AB (Publ). Övriga Tackling diabetes first. Brighter has developed the Actiste® product portfolio to support people living with diabetes. Click here for further information.

Ericsson (NASDAQ: ERIC) and its partner Brighter, a Swedish health-tech company focused on improving chronic disease management, have introduced Actiste®, the world's first complete IoT-health solution for monitoring and treating insulin-dependent diabetes.
Uppsagningstid tillsvidareanstalld

Measurement of glucose levels, insulin injection, and automatic logging and timing of all activity are done in a single unit. Brighter’s subsidiary Nectarine Health is on a mission to help seniors live in their homes for longer. The company’s story is one of clever technology, identifying an unmet need, and making the decision to pivot in a new direction. Read the full article here.

Brighter AB (publ), a health-tech company, develops data-driven solutions for the treatment of chronic condition in Sweden. It is developing Actiste, 7 Jan 2020 The developer, Brighter AB (publ), has not provided details about its privacy practices and handling of data to Apple.
Fa battre sjalvkansla

lund driving schools
din framtidsbutik
stjäla stjäler
cafe årsta torg
antal mobila bankid swedbank
kvinnligt natverk
tangram puzzles printable pdf

17 Sep 2019 With patient consent, Actiste also sends data to Brighter's The Benefit Loop open Actiste Diabetes Management as a Service (MaaS) is a

Brighter often refers to the benefit loop, which illustrates how Actiste benefits everyone. The device makes life easier for people with diabetes, lets caregivers provide better patient support, provides medical data for research and reduces overall lifecycle costs.

Dygder betyder
vad betyder makro

Om Actiste. Brighters lösning Actiste® hanterar de flesta moment i självmonitorering och behandling av insulinbehandlad diabetes genom ett enda lättanvänt verktyg. Mätning av glukosnivåer, injicering av insulin samt automatisk loggning och tidsstämpling av all aktivitet görs i en enda enhet.

2020-06-07 · A ‘Brighter’ future with Actiste® IoT healthcare solution. Brighter is a health-tech company from Sweden, founded in 2007, with a vision to improve quality of life and reduce the complications of chronic diseases. Brighter developed Actiste®, the world’s first unified Brighter initiated activity on multiple fronts following the issue of CE marks for its lead product, Actiste. It acquired Nectarine Health, a Swedish healthtech start-up, to complement its other assisted care solutions acquisition, Camanio. Brighter also entered into a strategic partnership with Accumbo, a digital healthcare provider, to support the visibility of Actiste in the Swedish market Brighter Sweden. Norgegatan 2 164 32 Kista, Sweden Phone: +46 (0)8-550 088 20 Fax: +46 (0)8-550 088 30.

The diabetes management system Actiste combines a blood glucose meter with a lancet and an injection pen. Thanks to the Brighter, Stockholm, Sweden.

2020-06-07 SWEDEN – July 7, 2016 – Brighter AB today announced a partnership with Sanmina to produce the first generation of Actiste®, a connected diabetes device that allows users to monitor blood sugar, inject insulin and log blood sugar levels and insulin doses in a single device. Sanmina is a global Tier 1 provider of integrated manufacturing solutions, making some of the world’s most complex Learn more about Actiste: https://actiste.com/Learn more about Brighter: https://www.brighter.se/ Brighters banbrytande diabeteslösning Actiste® har erhållit marknadsgodkännande i Saudiarabien mån, nov 02, 2020 15:23 CET. Brighter AB (Publ) är stolt att tillkännage att bolagets banbrytande lösning för diabetesvård – Actiste®-enheten och dess tillhörande digitala plattform – har erhållit marknadsgodkännande från SFDA (Saudi Food and Drug Authority) i Saudiarabien. This is the market served by Brighter subsidiary Camanio Care. Since 2011, the company has delivered welfare-assistance technology to more than 50% of Sweden’s 290 municipalities. Camanio Care’s offering used to be about devices, but under the leadership of CEO Catharina Borgenstierna the company is now focusing exclusively on developing its digital service platform: Camanio SmartCare.

It is initially being introduced in the UAE, powered by Ericsson’s IoT platform. Brighter har under det senaste året uppnått flera viktiga operativa mål i flera länder för att etablera Bolagets lösningar för effektiv datadriven hälsovård. CE-godkända Actiste® för insulinbehandlad diabetes har nyligen fått marknadsgodkännande i Saudiarabien samt Förenade Arabemiraten. Om Actiste.